Similar articles

• Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.

  Gómez-Martín C, Concha A, Corominas JM, García-Caballero T, García-García E, Iglesias M, López JA, Ramón y Cajal S, Rojo F, Palacios J, Vera-Sempere F, Aranda E, Colomer R, García-Alfonso P, Garrido P, Rivera F, López-Ríos F; Spanish Society of Medical Oncology; Spanish Society of Pathology. Gómez-Martín C, et al. Clin Transl Oncol. 2011 Sep;13(9):636-51. doi: 10.1007/s12094-011-0709-7. Clin Transl Oncol. 2011. PMID: 21865135
• The distinctive nature of HER2-positive gastric cancers.

  Marano L, Roviello F. Marano L, et al. Eur J Surg Oncol. 2015 Mar;41(3):271-3. doi: 10.1016/j.ejso.2014.12.007. Epub 2015 Jan 10. Eur J Surg Oncol. 2015. PMID: 25605551 No abstract available.
• THE STUDY OF THE EXPRESSION OF CDH1, KI67, P53 AND HER2 IN DIFFUSE GASTRIC CARCINOMA.

  Muzashvili T, Tutisani A, Chabradze G, Beridze N, Museridze N. Muzashvili T, et al. Georgian Med News. 2020 Feb;(299):147-150. Georgian Med News. 2020. PMID: 32242863
• [HER2 testing in gastric cancer : Results of a meeting of German experts].

  Baretton G, Dietel M, Gaiser T, Kirchner T, Kreipe HH, Quaas A, Röcken C, Rüschoff J, Tannapfel A, Lordick F, Al-Batran S, Hofheinz R, Lorenzen S, Moehler M, Thuss-Patience P. Baretton G, et al. Pathologe. 2016 Jul;37(4):361-6. doi: 10.1007/s00292-016-0179-3. Pathologe. 2016. PMID: 27376648 German.
• HER2 testing in gastric cancer: results of a German expert meeting.

  Lordick F, Al-Batran SE, Dietel M, Gaiser T, Hofheinz RD, Kirchner T, Kreipe HH, Lorenzen S, Möhler M, Quaas A, Röcken C, Rüschoff J, Tannapfel A, Thuss-Patience P, Baretton G. Lordick F, et al. J Cancer Res Clin Oncol. 2017 May;143(5):835-841. doi: 10.1007/s00432-017-2374-x. Epub 2017 Mar 11. J Cancer Res Clin Oncol. 2017. PMID: 28285403 Free PMC article. Review.